Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.525 USD | +4.29% | -8.27% | +140.56% |
05-08 | Transcript : ChromaDex Corporation, Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Earnings Flash (CDXC) CHROMADEX CORPORATION Reports Q1 Revenue $22.2M, vs. Street Est of $23.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+140.56% | 255M | |
+29.41% | 48.16B | |
-0.42% | 41.73B | |
+43.51% | 41.03B | |
-5.31% | 28.77B | |
+11.00% | 25.59B | |
-22.26% | 18.96B | |
+8.74% | 12.92B | |
+28.59% | 12.03B | |
-2.09% | 11.77B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- ChromaDex : B Riley Raises ChromaDex' Price Target to $18 from $7, Cites Favorable Clinical Studies Reflecting Potentially Broad Relevance; Keeps Buy Rating